Eprosartan Mesylate Articles

Solvay's 2005 revenue reaches 8.5 B euros

27 February 2006

Kos enters cardiovascular R&D alliance with Biovail

9 May 2005

Biovail revises full-year outlook on robust sales

20 September 2004

FDA clears Biovail's Cardizem LA for the treatment of angina

12 April 2004

Novel promotion deal for Altana and Solvay

29 March 2004

Sales and profits down at Belgium's Solvay

11 August 2003

Biovail gets US OK for Teveten HCT

3 March 2003

Solvay pharma earnings grow 13%

17 February 2003

Biovail gets US approval for long-acting Cardizem LA; launch in April

17 February 2003

Strong quarter for Canada's Biovail

6 May 2002

Biovail buys Teveten US rights from Solvay

25 March 2002

Pretax profits down at Belgium's Solvay

18 February 2002

Belgium's Solvay places emphasis on growing pharmaceuticals further

12 February 2001

Unimed files for blood pressure combo

26 October 2000

Belgium's Solvay buys Sintofarma of Brazil

4 October 2000

US DTC spending set to pass $2 billion in 2000; COX-2 inhibitors lead in 1st

14 August 2000

SB, Aventis in alleged bribes scandal

16 May 2000

Solvay's Teveten launched in UK

14 April 2000

Profits and cash flow advances for Solvay

14 February 2000

Stock Commentary Europe

9 September 1999

Solvay's Teveten, more effective than other ARBs?

3 September 1999

Solvay looking for strong pharma growth

5 August 1999

Solvay Group agrees to acquire Unimed Pharmaceuticals for $123 million

14 June 1999

Solvay licenses Teveten from SB

13 May 1999

Beyond ACE inhibition: the future of angiotensin I inhibitors

11 February 1999

Telmisartan Becomes Sixth AIIRA To Be Registered

19 November 1998

UK Pharma Leaders Outline Strategy

22 June 1998

SB Defends Independence On Strong R&D Grounds

23 April 1998

GW Makes Foray Into Cardiovascular Arena

18 March 1998

GW-SB Merger Will Create R&D Superpower

5 February 1998

Wyeth-Ayerst's Verdia Cleared By FDA Panel

4 February 1998

1997: Another Good Year For New Chemical Entities

6 January 1998

Teveten Approved In USA

29 December 1998

Comarketing Deal For Eprosartan

9 October 1997

Irbesartan Debuts In The UK And Germany

25 September 1997

Irbesartan To Reach First Markets This Month

3 September 1997

SB's Eprosartan Debuts In Germany

31 July 1997

Upbeat UK Companies At Goldman Sachs Conference

17 June 1997

First Approval Of SB's Teveten, In Germany

9 June 1997

Showing 1-39 of 39 articles

Go to beginningPrevious
  • 1
NextGo to end